- By Aditya Pratap Singh
- Tue, 16 Jun 2026 03:24 PM (IST)
- Source:JND
Pharma Stock Under Rs 50: Shares of small-cap pharma company Sudarshan Pharma Industries continued their gaining momentum for the fourth straight session to hit a fresh 52-week high on Tuesday. Today's uptick momentum was seen after the company said that its board of directors will have a meeting soon to consider a proposal to raise funds through a preferential issue or any other method.
The stock started the session in green at Rs 37.50 as compared to the last day's closing of Rs 37.17 on BSE amid a rally in benchmark indices Sensex and Nifty. Going forward, the stock joined the market momentum and escalated further to hit a 52-week high at Rs 38. Meanwhile, the 52-week low value of the stock stood at Rs 18.50, which the shares touched on January 29, 2026.
Also Read: Despite Import Duty Hike And PM’s Appeal, India’s Gold Imports Continue To Climb, Jump 34% In May
Share Price History
According to BSE Analytics, in the last five sessions, the stock jumped over 7 per cent. In a period of three years, the stock soared by over 438 per cent. This year till date (YTD), the scrip soared nearly 35 per cent; meanwhile, the Sensex corrected over 10 per cent this year.
Stock Market Today
Benchmark stock indices Sensex and Nifty rose for the third consecutive day on Tuesday on the back of firm global cues and softening crude oil prices following a peace deal between the US and Iran.
The 30-share BSE's index 'Sensex' settled 544.15 points, or 0.71 per cent higher at 76,808.48. It had gained 582.41 points, or 0.76 per cent, to 76,846.74 points during the day. The 50-share NSE Nifty ended up 135.25 points, or 0.57 per cent, to 23,989.15 points.
During the session, the Nifty index gained 148.7 points, or 0.62 per cent, to 24,002.60 points during the day. Today's rally was buoyed by foreign investors becoming direct buyers in the Indian stock market.
Disclaimer: This story has been directly published from the agency feed. No changes have been made except the headline.
